Novel induction therapy transoral surgery treatment paradigm with risk-adapted adjuvant therapy for squamous cell carcinoma of the head and neck – Mature clinical and functional outcomes-Reference-Cited by-同舟云学术

Novel induction therapy transoral surgery treatment paradigm with risk-adapted adjuvant therapy for squamous cell carcinoma of the head and neck – Mature clinical and functional outcomes

Published:2020-11 Issue: Volume:110 Page:104957
ISSN:1368-8375
Container-title:Oral Oncology
language:en
Short-container-title:Oral Oncology

Author:

Hackman Trevor G.^ORCID,Patel Samip N.,Deal Allison M.,Neil Hayes D.,Chera Bhishamjit S.,Paul Jennifer,Knowles Mary,Usenko Dmitriy,Grilley-Olson Juneko E.,Weissler Mark C.,Weiss Jared^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Oral Surgery

Reference41 articles.

1. Pazdur R, Wagman L, Camphausen K, et al., editors. 12th ed. Cancer Management: A Multidisciplinary Approach. Norwalk, Connecticut: CMP Healthcare Media LLC; 2009.

2. National Comprehensive Cancer Network Head and Neck Cancers V 1.2012. Available at http://www.nccn.org. [accessed May 12, 2013].

3. Forastiere AA, Goepfert H, Maor M, et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med. 2003 Nov 27; 349(22):2091-8. [Medline].

4. Combined postoperative radiotherapy and weekly cisplatin infusion for locally advanced head and neck carcinoma: final report of a randomized trial;Bachaud;Int J Radiat Oncol Biol Phys,1996

5. Phase 2 trial of de-intensified chemoradiation therapy for favorable-risk human papillomavirus-associated oropharyngeal squamous cell carcinoma;Chera;Int J Radiat Oncol Biol Phys,2015

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the Therapeutic Implications of Co-Targeting the EGFR and Spindle Assembly Checkpoint Pathways in Oral Cancer;Pharmaceutics;2024-09-11

2. Clinical Characteristics and Treatment Outcomes of Oral Cancers Using Transoral Robotic Surgery in an Endemic Region;Cancers;2023-10-09

3. Emerging tyrosine kinase inhibitors for head and neck cancer;Expert Opinion on Emerging Drugs;2022-07-03

4. Comprehensive Analysis of mTORC1 Signaling Pathway–Related Genes in the Prognosis of HNSCC and the Response to Chemotherapy and Immunotherapy;Frontiers in Molecular Biosciences;2022-04-29

5. Treatment outcomes of neoadjuvant chemotherapy and transoral robotic surgery in locoregionally advanced laryngopharyngeal carcinoma;Head & Neck;2021-08-06